about
ApoE production in human monocytes and its regulation by inflammatory cytokinesRole of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesImmunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortalityImmunity, atherosclerosis and cardiovascular diseaseIncreased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage?Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study.Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health studyCardiovascular involvement in autoimmune diseases.Gluten-free diet in nonceliac disease.Microcirculation as determined by iontophoresis in SLE-patients and controls.Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective studyIncreased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosusAntibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis.The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.Cardiovascular co-morbidity in patients with rheumatic diseases.Preliminary Report of Endovascular Treatment for Critical Limb Ischemia Patients with Connective Tissue Disease: Cases Series and Review of the Literature.Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus.Risk factors for coronary heart disease in connective tissue diseasesThe association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaquesTherapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus.Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study.Atherogenesis and the humoral immune response to modified lipoproteinsBirth weight and coronary artery disease. The effect of gender and diabetesThe inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.Immune mechanisms in atherosclerosis, especially in diabetes type 2Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Effects of Thyroid Autoimmunity on Early Atherosclerosis in Euthyroid Girls with Hashimoto's Thyroiditis.Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis.T-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis.High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.ACP1 Genetic Polymorphism and Coronary Artery Disease: Evidence of Effects on Clinical Parameters of Cardiac Function.The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis.The clinical significance of coagulation and the inflammatory response in autoimmunity.Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis.Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis.Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.
P2860
Q21559536-CBA16E9C-4AF3-4D8F-A331-8375C1D3BE01Q27008359-DBEFDD38-CBE7-40DC-9E75-69234E8AB8C9Q28390958-01642994-6418-4262-9FEC-EAFF6D8DC12AQ28688590-F82A7B77-8B4B-4F8F-BAFE-3DD9678FE574Q30983662-B60BB7A7-6856-4D73-AB6A-6EF926FFBC02Q31005025-448E5A85-AF3C-4FCA-9680-31ED8F16B31EQ33581439-1F41DD1C-D399-4C35-9A4E-649F5C336436Q34017775-22DEB322-197F-4247-AF1A-3B478DA76E0DQ34081242-6199D758-2F2D-48AA-BD09-444CD61C9DDEQ34185602-365716AE-61A9-404D-B7DB-2F959009BDF6Q34194913-7191E2B4-E6E8-4410-824B-C763FAD748D8Q34420240-ABD29E3E-9C14-4B1C-A3AE-6BDD60F4C2BAQ34538210-D5FA788F-0BB7-4521-8EEA-7FA80A8624BDQ34613997-5F26E3F2-2272-41EA-98E6-7D214895D16EQ34634016-0B205A80-7F2E-42EE-AE55-9EF74E22C34AQ35213557-E5BDFF06-4477-4371-9255-7F713DA1C226Q35238112-7A5C7581-62A9-4094-908E-0FF28EF292B5Q35387131-50C2E27B-25CB-4A1B-B10D-E2A080AAA03FQ35557796-CF60DA97-90ED-4220-8822-57551EE445D7Q35675329-20DD8D2E-9234-4131-BB9E-8DF95053B327Q35954549-8638D92C-509D-46F2-9E25-9F6647AF2748Q36056947-EBF133D3-9963-4790-80D7-B673B439C81DQ36334087-0275458E-230E-4D16-9717-24BA7C34DEF2Q36611056-764E9137-2919-427E-8B6A-A037549F7FB0Q36757006-9D06DBB1-3443-4E2E-8482-4BB15E3600BDQ37021490-654B2E91-4371-4571-8164-F89D1AC82473Q37118366-9F291FE4-0AB5-4023-A19A-1639DC92D990Q37206876-E0F7C9E2-0F1D-49F2-BC17-516EA548CC6BQ37261617-026B297D-9615-454A-B30D-AE28ED419F8AQ37330468-75ED8C0F-20B1-4E39-A6F2-5A65876560CCQ37395066-4FE3FAE7-A092-4654-A494-5363D7C04EABQ37412379-28882E84-5FC6-4598-AC46-289D8998B8BCQ37660865-036D2FAC-AA5E-4F76-B9FB-3671E0520EB7Q37670939-4A87FBBB-CFC2-4BFF-830C-09149CF54203Q37711417-3960EA0B-2940-4C46-85A1-D1BD32CD77D9Q37817050-EFC93B37-BA15-4111-AA0A-E10D86ED1D5EQ37827404-054ED656-19B4-4EC8-B863-7EFBF14511E2Q38214567-8993BE3E-C88B-44C3-B964-52D3924D56B7Q38263671-E3F4861E-E9BC-49EC-AE4D-200AF451ED29Q38291820-A4901B35-B3E6-48DD-9A81-74413D2F7E1F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Atherosclerosis in patients with autoimmune disorders.
@ast
Atherosclerosis in patients with autoimmune disorders.
@en
type
label
Atherosclerosis in patients with autoimmune disorders.
@ast
Atherosclerosis in patients with autoimmune disorders.
@en
prefLabel
Atherosclerosis in patients with autoimmune disorders.
@ast
Atherosclerosis in patients with autoimmune disorders.
@en
P1476
Atherosclerosis in patients with autoimmune disorders.
@en
P2093
Johan Frostegård
P304
P356
10.1161/01.ATV.0000174800.78362.EC
P407
P577
2005-06-23T00:00:00Z